# Doxorubicin With or Without Sildenafil, With Analysis of Cardiac Markers

> **NCT01375699** · PHASE1 · COMPLETED · sponsor: **Virginia Commonwealth University** · enrollment: 26 (actual)

## Conditions studied

- Breast Cancer
- Gastrointestinal Cancer
- Genitourinary Cancer
- Sarcoma
- Gynecologic Cancer

## Interventions

- **DRUG:** Doxorubicin
- **DRUG:** Sildenafil

## Key facts

- **NCT ID:** NCT01375699
- **Lead sponsor:** Virginia Commonwealth University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08-11
- **Primary completion:** 2017-08-04
- **Final completion:** 2018-01-19
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2019-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01375699

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01375699, "Doxorubicin With or Without Sildenafil, With Analysis of Cardiac Markers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01375699. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*